Module 1: Oncology Clinical Trials — What Makes Them Different

Overview:

This module introduces the oncology clinical development landscape and highlights how oncology trials differ from other drug trials, focusing on patient population complexity, ethical considerations, and operational implications.

Key topics:

• •Oncology vs non-oncology trial characteristics
• •Patient population and ethical considerations
• •Disease progression vs treatment-related effects
• •Overview of oncology development pathways

Module 2 – Oncology Trial Designs and Innovative Approaches

Overview:

Participants explore traditional and innovative oncology trial designs and understand how design choices impact operations, monitoring, and timelines.

Key topics:

• •Traditional vs innovative oncology trial designs
• •Adaptive, basket, and umbrella trials
• •Early-phase dose escalation and expansion cohorts
• •Combination therapies and biomarker-driven design
• Interactive element: Case-based protocol discussion

Module 3 – Oncology Endpoints and Tumor Assessments — Operational Impact and Monitoring Risks

Overview:

This module focuses on oncology endpoints and tumor assessments from an operational and monitoring perspective, emphasizing where errors commonly occur and how they impact trial integrity.

Key topics:

• •Key oncology endpoints from an operational lens
• •Tumor assessment schedules and imaging windows
• •Common endpoint-related deviations and data quality risks
• Interactive element: Endpoint and imaging timeline exercise

Module 4 – Patient Safety and Risk Management in Oncology

Overview:

Participants learn how safety oversight in oncology differs from other therapeutic areas and how to manage complex safety profiles in high-risk patient populations.

Key topics:

• •Safety profiles of oncology therapies (chemotherapy, immunotherapy, targeted agents)
• •Differentiating disease-related symptoms from treatment-related AEs
• •SAE reporting challenges and timelines
• •Dose modifications, treatment interruptions, and risk mitigation strategies
• Interactive element: Scenario-based safety assessment

Wrap-Up and Open Q&A

Module 5: Site Selection, Start-Up, and Enrollment in Oncology Trials

Overview:

This module examines the unique challenges of site selection and enrollment in oncology trials, including feasibility, competing studies, and biomarker testing timelines.

Key topics:

• •Oncology site ecosystems and feasibility assessments
• •Site workload and competing trial considerations
• •Biomarker testing and eligibility confirmation
• •Enrollment pressure and compliance risks
• Interactive element: Site feasibility decision exercise

Module 6: Clinical Monitoring in Oncology Trials — Priorities, Red Flags, and Best Practices

Overview:

This core module focuses on how to monitor oncology trials effectively, highlighting differences from non-oncology trials and identifying critical data and risks.

Key topics:

• •How oncology trial monitoring differs from other drug trials
• •Monitoring priorities: safety, eligibility, and efficacy endpoints
• •Source documentation complexity in oncology settings
• •Risk-based monitoring approaches tailored to oncology
• •Common red flags at the patient, site, and study level
• •Escalation strategies and inspection expectations
• Interactive element: Monitoring scenario and group debrief

Module 7: Data Quality, Compliance, and Inspection Readiness in Oncology Trials

Overview:

Participants learn how data quality and compliance issues arise in oncology trials and how proactive monitoring and documentation support inspection readiness.

Key topics:

• •Data integrity risks specific to oncology trials
• •Common inspection findings
• •Protocol deviations and amendment management
• •Role of monitoring documentation in inspections

Module 8: Operational Excellence Across the Oncology Trial Lifecycle

Overview:

This module integrates operational best practices across the study lifecycle, focusing on managing complexity, vendors, and cross-functional communication.

Key topics:

• •Managing protocol complexity and frequent amendments
• •Vendor coordination (central labs, imaging, specialty vendors)
• •Communication breakdowns and mitigation strategies
• •Continuous improvement and lessons learned

Closing Session: Knowledge Check and Interactive Wrap-Up

Overview:

• •Interactive knowledge quiz covering key course concepts
• •Group discussion of case-based questions
• •Open Q&A and participant-driven discussion
• •Key takeaways and practical tips for immediate application